Crealta Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Crealta Pharmaceuticals has a total of 141 patents globally, out of which 61 have been granted. Of these 141 patents, more than 26% patents are active. Japan is where Crealta Pharmaceuticals has filed the maximum number of patents, followed by Israel and United States of America. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Crealta Pharmaceuticals.

Crealta Pharmaceuticals was founded in 2013. The company manufactures therapeutic products like Krystexxa and Migergot for treating high uric acid and migraines respectively.

Do read about some of the most popular patents of Crealta Pharmaceuticals which have been covered by us in this article and also you can find Crealta Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Crealta Pharmaceuticals patent portfolio.

How many patents does Crealta Pharmaceuticals have?

Crealta Pharmaceuticals has a total of 141 patents globally. These patents belong to 29 unique patent families. Out of 141 patents, 38 patents are active.

How Many Patents did Crealta Pharmaceuticals File Every Year?

Crealta Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCrealta Pharmaceuticals Applications FiledCrealta Pharmaceuticals Patents Granted
20211
20191
20182
201712
201612
201536
20146
201323
201215
201183

How many Crealta Pharmaceuticals patents are Alive/Dead?

Worldwide Patents

Crealta Pharmaceuticals Patent Portfolio

How Many Patents did Crealta Pharmaceuticals File in Different Countries?

Crealta Pharmaceuticals Worldwide Patent Filing

Countries in which Crealta Pharmaceuticals Filed Patents

CountryPatent
Japan24
Israel15
United States of America14
China11
Singapore8
Australia7
India7
Europe (EPO)6
Poland6
Mexico4
Hong Kong (S.A.R.)4
South Africa4
Canada4
Spain4
Austria4
Hungary3
Czech Republic3
Denmark2
Brazil2
Malaysia1
Germany1
Taiwan1
Portugal1
Korea (South)1
Ireland1

Where are Research Centers of Crealta Pharmaceuticals Patents Located?

R&D Centres of Crealta Pharmaceuticals

10 Best Crealta Pharmaceuticals Patents

US6590074B1 is the most popular patent in the Crealta Pharmaceuticals portfolio. It has received 37 citations so far from companies like Children’s Medical Center Corporation, Araim Pharmaceuticals, Siliconware Precision Industries.

Below is the list of 10 most cited patents of Crealta Pharmaceuticals:

Publication NumberCitation Count
US6590074B137
US6559124B123
US7115571B111
JP2013090636A7
US7135461B14
US7524818B23
CN102807973A3
CN1678348A3
US7754688B22
US7109168B12

What are Crealta Pharmaceuticals key innovation segments?

What Technologies are Covered by Crealta Pharmaceuticals?

The chart below distributes patents filed by Crealta Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Crealta Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Crealta Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Crealta Pharmaceuticals?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.